Neil Anderson

Neil G.
Anderson

Associate

Associate

Education
  • Cornell Law School (J.D., 2015) magna cum laude; Order of the Coif
  • Brigham Young University (B.S., 2012, Chemistry)
Admissions
  • California

Neil Anderson practices complex commercial litigation with an emphasis on intellectual property litigation. He has extensive experience litigating intellectual property disputes and has represented clients in federal district courts, the Patent Trial and Appeal Board, and the International Trade Commission. Mr. Anderson consistently implements creative, effective strategies that position his clients favorably—whether for trial or settlement.

Recently, he helped secure a favorable settlement for a generic drug manufacturer in a suit challenging the patents for a topical drug formulation. Mr. Anderson also assisted in the successful defense of a $466.8 million jury verdict, the largest intellectual property award of 2014.

Prior to joining Hueston Hennigan, Mr. Anderson was a litigation associate with Knobbe Martens. During law school, he was a managing editor of the Cornell Law Review and a Charles Evans Hughes Scholar. Mr. Anderson also served as an Honors Fellow for Cornell’s lawyering program, providing instruction and feedback to first-year students on legal research and writing assignments. In 2013, he externed for the Honorable Jean P. Rosenbluth of the U.S. District Court for the Central District of California.

As part of Mr. Anderson’s undergraduate studies in chemistry, he collaborated on developing microfluidic tools to help physicians quantify biomarkers that are indicative of disease. He also helped synthesize a series of small RNA-binding compounds as a potential new method of treating HIV and bacterial infections.

Experience

Won a motion for preliminary injunction for ClearOne Inc. in a patent infringement suit, enjoining a large, multinational competitor’s manufacture, marketing, and sale of a competing, infringing product.

Represent biotech firm Sorrento Therapeutics as plaintiff in multiple litigations alleging a high profile business partner’s scheme to “catch and kill” Sorrento’s promising cancer drug, Cynviloq.

Obtained favorable settlement for Peloton Interactive Inc. – including admissions of patent validity, intentional copying and an agreement to immediately cease using Peloton’s patented leaderboard technology – after prevailing on an Alice challenge and virtually every other motion. (See “Peloton, Flywheel Settle Legal Disputes Over Fitness Bike Tech,” Wall Street Journal; “Peloton, Flywheel Agree To End Patent Fight Over Bike Tech,” Law360).

Represented Best Buy Stores and Amazon.com in the Eastern District of Texas in a patent suit involving multiple patents directed to “smart home” technology.

Activities

Associate Board, Constitutional Rights Foundation, Orange County